Lake Point Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-47
Closed -$6K 460
2022
Q1
$6K Hold
47
﹤0.01% 221
2021
Q4
$8K Buy
+47
New +$7.15K ﹤0.01% 197

Other funds holding DGX

Lake Point Wealth Management's DGX Position: Q2 2022 in Review

Lake Point Wealth Management sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 47 shares — an estimated $6K sold.

Lake Point Wealth Management first reported a position in DGX in Q4 2021 and held it in 2 quarters. The position peaked at $8K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

  • Lake Point Wealth Management reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Lake Point Wealth Management sold 47 Quest Diagnostics shares in Q2 2022, an estimated $6K.
  • Lake Point Wealth Management first reported a position in Quest Diagnostics in Q4 2021 and held it in 2 quarters.
  • Lake Point Wealth Management's Quest Diagnostics position peaked at $8K in Q4 2021.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on Lake Point Wealth Management's 13F filing for Q2 2022, filed 19 Jul 2022.